John-Hendrik Jordan

1.1k total citations
14 papers, 769 citations indexed

About

John-Hendrik Jordan is a scholar working on Immunology, Hematology and Rheumatology. According to data from OpenAlex, John-Hendrik Jordan has authored 14 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 5 papers in Hematology and 4 papers in Rheumatology. Recurrent topics in John-Hendrik Jordan's work include Mast cells and histamine (13 papers), Eosinophilic Disorders and Syndromes (4 papers) and Platelet Disorders and Treatments (3 papers). John-Hendrik Jordan is often cited by papers focused on Mast cells and histamine (13 papers), Eosinophilic Disorders and Syndromes (4 papers) and Platelet Disorders and Treatments (3 papers). John-Hendrik Jordan collaborates with scholars based in Austria, Germany and Spain. John-Hendrik Jordan's co-authors include Peter Valent, Wolfgang R. Sperr, Hans‐Peter Horny, G. Schernthaner, Klaus Lechner, Luís Escribano, Michael Kundi, Andreas Chott, H. Semper and Michael Fiegl and has published in prestigious journals such as Blood, American Journal Of Pathology and Allergy.

In The Last Decade

John-Hendrik Jordan

14 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John-Hendrik Jordan Austria	13	641	361	225	135	125	14	769
Akif Selim Yavuz Türkiye	10	458 0.7×	287 0.8×	104 0.5×	119 0.9×	69 0.6×	34	647
Horny Hp Germany	12	316 0.5×	224 0.6×	67 0.3×	75 0.6×	44 0.4×	23	434
Sabrina Colarossi Italy	9	277 0.4×	537 1.5×	299 1.3×	71 0.5×	54 0.4×	21	1.1k
Beate Böhm Germany	14	236 0.4×	174 0.5×	106 0.5×	139 1.0×	53 0.4×	23	519
Alicia Humbría Spain	8	183 0.3×	136 0.4×	172 0.8×	56 0.4×	23 0.2×	11	430
L. A. M. Van Den Bersselaar Netherlands	7	224 0.3×	230 0.6×	52 0.2×	167 1.2×	22 0.2×	9	478
T Nakahata Japan	13	309 0.5×	31 0.1×	72 0.3×	198 1.5×	93 0.7×	30	634
Renate E. Gay United States	7	118 0.2×	209 0.6×	56 0.2×	165 1.2×	12 0.1×	7	497
Do‐June Min South Korea	9	152 0.2×	145 0.4×	54 0.2×	150 1.1×	9 0.1×	12	458

Countries citing papers authored by John-Hendrik Jordan

Since Specialization

Citations

This map shows the geographic impact of John-Hendrik Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John-Hendrik Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John-Hendrik Jordan more than expected).

Fields of papers citing papers by John-Hendrik Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John-Hendrik Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John-Hendrik Jordan. The network helps show where John-Hendrik Jordan may publish in the future.

Co-authorship network of co-authors of John-Hendrik Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of John-Hendrik Jordan. A scholar is included among the top collaborators of John-Hendrik Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John-Hendrik Jordan. John-Hendrik Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Laffer, Sylvia, Christian Lupinek, Ingrid Rauter, et al.. (2008). A high‐affinity monoclonal anti‐IgE antibody for depletion of IgE and IgE‐bearing cells. Allergy. 63(6). 695–702. 18 indexed citations

Jordan, John-Hendrik, Eliézer Jäger, Wolfgang R. Sperr, et al.. (2003). Numbers of colony‐forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders. European Journal of Clinical Investigation. 33(7). 611–618. 5 indexed citations

Baghestanian, Mehrdad, John-Hendrik Jordan, Hans P. Kiener, et al.. (2002). Activation of Human Mast Cells through Stem Cell Factor Receptor (KIT) Is Associated with Expression of bcl-2. International Archives of Allergy and Immunology. 129(3). 228–236. 27 indexed citations

Wimazal, Friedrich, John-Hendrik Jordan, Wolfgang R. Sperr, et al.. (2002). Increased Angiogenesis in the Bone Marrow of Patients with Systemic Mastocytosis. American Journal Of Pathology. 160(5). 1639–1645. 36 indexed citations

Jordan, John-Hendrik, G. Schernthaner, Robert Fritsche‐Polanz, et al.. (2002). Stem Cell Factor-induced Bone Marrow Mast Cell Hyperplasia Mimicking Systemic Mastocytosis (SM): Histopathologic and Morphologic Evaluation with Special Reference to Recently Established SM-criteria. Leukemia & lymphoma. 43(3). 575–582. 19 indexed citations

Sperr, Wolfgang R., John-Hendrik Jordan, Michael Fiegl, et al.. (2002). Serum Tryptase Levels in Patients with Mastocytosis: Correlation with Mast Cell Burden and Implication for Defining the Category of Disease. International Archives of Allergy and Immunology. 128(2). 136–141. 141 indexed citations

Jordan, John-Hendrik, Robert Fritsche‐Polanz, Wolfgang R. Sperr, et al.. (2001). A case of ‘smouldering’ mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val. Leukemia Research. 25(7). 627–634. 33 indexed citations

Jordan, John-Hendrik, Sabine Walchshofer, W. Jurecka, et al.. (2001). Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-xL. Human Pathology. 32(5). 545–552. 83 indexed citations

Wimazal, Friedrich, Wolfgang R. Sperr, Michael Kundi, et al.. (2001). Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes. Leukemia Research. 25(4). 287–294. 34 indexed citations

10.

Sperr, Wolfgang R., Luís Escribano, John-Hendrik Jordan, et al.. (2001). Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leukemia Research. 25(7). 529–536. 143 indexed citations

11.

Schernthaner, G., John-Hendrik Jordan, Minoo Ghannadan, et al.. (2001). Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood. 98(13). 3784–3792. 44 indexed citations

12.

Sperr, Wolfgang R., John-Hendrik Jordan, Mehrdad Baghestanian, et al.. (2001). Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood. 98(7). 2200–2209. 103 indexed citations

13.

Samorapoompichit, Puchit, Hans P. Kiener, G. Schernthaner, et al.. (2001). Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms. Blood. 98(8). 2580–2583. 48 indexed citations

14.

Wimazal, Friedrich, Minoo Ghannadan, Michael Müller, et al.. (1999). Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi‐color flow cytometry and toluidine blue/immunofluorescence staining techniques. Tissue Antigens. 54(5). 499–507. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact